Search results
From 2010 through 2013, Dr. Mendelsohn was the senior vice president and global head of cardiovascular research at Merck Research Laboratories, with overall responsibility for the scientific direction of cardiovascular research from drug discovery through late development.
Oct 27, 2021 · The cardiovascular-focused biotech was founded by former Merck executive Michael Mendelsohn, M.D., who currently serves as chairman. CEO Peter Lawrence joined as CEO in March 2020.
Aug 3, 2017 · Mendelsohn is executive chairman of the new biotech, and previously served as Senior Vice President and head of cardiovascular research for Merck Research Laboratories and chief...
Apr 15, 2020 · Michael Mendelsohn, founder of Cardurion and former head of cardiovascular research at Merck Research Laboratories, guided the startup to those investments in his capacity as interim CEO....
- Nick Paul Taylor
Apr 16, 2020 · Michael Mendelsohn, founder of Cardurion and former head of cardiovascular research at Merck Research Laboratories, guided the startup to those investments in his capacity as interim CEO. But with Cardurion moving deeper into the clinic, Mendelsohn is stepping aside to let Lawrence lead.
Michael Mendelsohn, MD From 2010 through 2013, Michael served as the senior vice president and head of cardiovascular research at Merck Research Laboratories, with overall responsibility for the scientific direction of cardiovascular research from drug discovery through late development.
Nov 30, 2022 · Dr. Mendelsohn is a Professor of Medicine at Tufts University School of Medicine. “We are thrilled to add an experienced cardiovascular leader and innovator of Michael’s caliber to our Strategic Advisory Board,” said Christopher Colecchi, Managing Director of Broadview Ventures.
